Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Ophth. Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Ophth. Other
    Eye Floaters, Flashes of Light Linked to Retinal Tear, Detachment - (DGNews)
    Acute-onset floaters and flashes: is this patient at risk for retinal detachment? - (JAMA)
    Proton Beam Radiation Therapy for Uveal Melanoma Yields Good Results at a Dose of 56 Gy: Presented at ASTRO - (DGDispatch)
    Intravitreal Triamcinolone Effective for Diabetic Macular Oedema - (DGNews)
    Topical Cyclosporine More Effective Than Artificial Tears for Treating Dry Eye: Presented at AAO-PAAO - (DGDispatch)

    News archive

     Recent webcasts/CME - Ophth. Other
    Treatment of Dry Eye
    Managing Age-Related Macular Degeneration - An Update

    Webcasts/CME archive

     Recent cases - Ophth. Other
      Frontal Skull Craniotomy Combined With Moderate-Dose Radiotherapy Effectively Ameliorate A Rare Case Of Non-Secretory, Multiple Myeloma With Orbital Involvement
      A Spontaneous Suprachoroidal Haemorrhage: A Case Report
      Long-Term Remission of Myopic Choroidal Neovascular Membrane After Treatment with Ranibizumab: A Case Report
      Ocular Disorders as the Prevailing Manifestations of Antiphospholipid Syndrome: A Case Series
      Primary Central Nervous System Lymphoma Presenting as Bilateral Uveitis in an Immunocompetent HCV+ Patient: A Case Report

      Cases archive
        




      my personal edition > ophth. other > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Intravitreal Injection of Triamcinolone Acetonide Improves Visual Acuity in Patients with Diffuse Diabetic Macular Ooedema: Presented at AAO/PAAO

      By Anne Jacobson
      Special to DG News

      ORLANDO, FL -- October 22, 2002 -- Intravitreal injection of 25 mg triamcinolone acetonide is an effective treatment for clinically significant diffuse diabetic macular oedema, new research suggests.

      Jost B. Jonas, MD, of the department of ophthalmology and eye hospital at the Friedrich-Alexander-University Erlangen-Nürnberg, in Erlangen, Germany, reported his findings here October 20 at the Joint Meeting of the American Academy of Ophthalmology and the Pan-American Association of Ophthalmology (AAO/PAAO).

      In this prospective study, Dr. Jonas evaluated 15 patients who received an intravitreal injection of 25 mg triamcinolone acetonide for treatment of diffuse diabetic macular oedema over a mean follow-up time of 5.2 months.

      Following treatment, visual acuity increased significantly from an average 0.08 at baseline to a maximum of 0.16 (p=0.004) at follow-up. Visual acuity improved by six weeks after treatment to an average 0.13 (p=0.003) and to 0.16 (p=0.018) by six months.

      Overall, nine eyes (90 percent) observed for at least one month were found to gain visual acuity.

      According to Dr. Jonas, the 25 mg dose used in this study is significantly higher than the 4 mg dose commonly used in clinical practice. Dr. Jonas says he believes that the frequencies of side effects are similar at the two doses, but that the 25 mg dose results in a much longer duration of effect.

      "We repeat the injections at four to nine months in all patients who experience an increase in visual acuity with the initial injection," Dr. Jonas told Doctor's Guide. In some patients who receive the 25 mg injection, the resulting increase in visual acuity persists for up to nine months.



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send